Bipartisan efforts are underway in the Senate to address psychedelics legislation, while recent developments in Mississippi reveal a veto from Governor Tate Reeves on medical marijuana expansion. Indiana’s Governor Mike Braun is initiating discussions around cannabis legalization amidst shifting public opinion, evidenced by a recent poll indicating that a majority of Americans now view cannabis use as morally acceptable.
Legislative Developments
Rep. Steve Cohen (D-TN) has reached out to Attorney General Pam Bondi and DEA Administrator Terrance Cole for updates on marijuana rescheduling following President Trump’s directive to expedite the process. The letter also highlights the Justice Department’s failure to meet a statutory deadline for issuing guidelines aimed at facilitating research into Schedule I substances such as cannabis and psychedelics.
Meanwhile, Senators Tim Sheehy (R-MT), Tammy Duckworth (D-IL), Ruben Gallego (D-AZ), and John Boozman (R-AR) have introduced a bill proposing the establishment of a new Department of Veterans Affairs office dedicated to advancing research on psychedelics and reassessing the scheduling of drugs like psilocybin and MDMA.
State-Level Actions
In Mississippi, Governor Reeves vetoed two bills intended to broaden medical cannabis access but approved legislation to encourage research on the psychedelic ibogaine. Indiana’s Governor Braun criticized Republican legislative leaders for their hesitance to reform marijuana laws, noting that a substantial number of Hoosiers likely consume cannabis illegally.
A recent poll underscores a significant cultural shift; it shows that majorities across various demographics, including age, gender, and political affiliation, believe cannabis use is not immoral. Interestingly, Republicans tend to view cannabis consumption as morally unacceptable at nearly twice the rate of Democrats.
In Kansas, law enforcement agencies are facing lawsuits from smoke and vape shops that argue officials are not effectively distinguishing between legal hemp and illicit cannabis products during recent enforcement actions.
Regulatory Updates
At the federal level, the DEA has continued to profile its special agents, highlighting their roles in drug enforcement. Legislative efforts are also continuing, with the House bill aimed at providing patients access to Schedule I drugs now featuring 17 cosponsors.
In state news, Utah’s Governor Spencer Cox signed bills to modify medical cannabis regulations, while Minnesota’s Governor Tim Walz allowed hemp edible manufacturers to utilize out-of-state testing until further notice. Conversely, the Oklahoma House of Representatives dismissed a bill permitting counties to impose taxes on medical cannabis.
The Pennsylvania Supreme Court has ruled that a cannabis trade association lacks the standing to challenge local restrictions on medical cannabis use for individuals on probation. Additionally, California has announced a recall of marijuana products due to labeling issues, and New Jersey’s leading cannabis regulator is stepping down amidst ongoing industry evolution.
Market Insights
In business developments, iAnthus Capital Holdings reported a quarterly revenue of $35.3 million, although with a net loss of $14.1 million. Jushi Holdings has successfully restructured its debt through a significant term loan.
As these developments unfold, stakeholders in the Mississippi cannabis sector and beyond are encouraged to stay informed and engaged as legislation, public opinion, and market dynamics continue to evolve.